Top Medical News
Roshini Claire Anthony, 3 hours ago

Individuals with attention-deficit hyperactivity disorder (ADHD) who are treated with atomoxetine or methylphenidate may have a risk for elevated heart rate and systolic blood pressure (BP), according to a meta-analysis.

3 hours ago
Use of bevacizumab in combination with temozolomide yields no survival gains when compared with temozolomide alone in the treatment of patients with grade 2–3 glioma, according to the results of the open-label phase II TAVAREC trial.
4 hours ago
The risk of sexual dysfunction (SD) is significantly increased in patients with rheumatoid arthritis (RA), according to a recent study, suggesting that both patients and clinicians must be aware of the potential role of RA in the development of SD.
Stephen Padilla, 5 hours ago
Singapore schoolchildren have shown improved attitudes towards providing cardiopulmonary resuscitation (CPR) and using an automated external defibrillator (AED) after undergoing a training programme, a study has shown. However, there are still concerns about hurting the victim when performing CPR.
6 hours ago
Obese and overweight individuals who wish to lose weight do not need extremely high levels of adherence to a behavioural weight management programme to achieve clinically significant weight loss, suggest the findings of a recent study.
8 hours ago
Smoking appears to increase the risk of abdominal aortic aneurysm, particularly among current smokers, reports a recent meta-analysis. The risk appears to taper with a lower number of cigarette sticks smoked per day.
11 hours ago
Use of rifaximin as a follow-on medication after successful treatment of Clostridium difficile infection in frail elderly patients appears to halve recurrence rate, according to the results of the RAPID* trial. However, the results do not rule out the possibility of no effect.
Special Reports
Dr. Robert Giugliano, Prof. Ulrich Laufs, Prof. Gaetano De Ferrari, Prof. Naveed Sattar, 11 Oct 2018

The FOURIER trial previously demonstrated that adding the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor evolocumab to background statin therapy lowered LDL-cholesterol (LDL-C) below target levels and significantly reduced the risks of cardiovascular (CV) events in patients with atherosclerotic cardiovascular disease (ASCVD). At the European Society of Cardiology (ESC) Congress 2018 in Munich, Germany, experts reiterated how evolocumab helps lower LDL-C levels and reduces CV events even in patients with various comorbidities.

02 Oct 2018
Type 2 diabetes mellitus (T2DM) is associated with substantial risks of cardiovascular disease (CVD) risk and overall mortality, despite the advances in treatment options.1 Recently, MIMS Doctor spoke to Dato’ Sri Dr Azhari Rosman, a Senior Consultant Cardiologist at the National Heart Institute, to provide an update on the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in managing CV risk associated with T2DM, and discuss the results of the recently published Comparative Effectiveness of Cardiovascular Outcomes (CVD-REAL) 2 study. Here are the highlights from the interview.
27 Sep 2018
PRALUENT – alirocumab 75 mg/mL and 150 mg/mL soln for inj - sanofi-aventis
27 Sep 2018
VICTOZA – Liraglutide 6 mg/mL soln for inj - Novo Nordisk
01 Sep 2018
The “Stay healthy: You call the shots” meeting, hosted by Sanofi Pasteur, was held at Thistle Port Dickson. During the meeting, Dr Ho Bee Kiau, Dr Leong Chee Loon and Dr Salehuddin Samsudin shared their insights into the role of influenza vaccination in reducing antimicrobial resistance (AMR), complications in high-risk patient populations, and dispelling vaccination myths among patients.
01 Sep 2018
Ischaemic heart disease was the principal cause of death in Malaysia in 2016, and ST-segment elevation myocardial infarction (STEMI) is noted as the deadliest clinical presentation of Acute Coronary Syndrome. At the National Heart Association of Malaysia’s 2018 Annual Scientific Meeting, Professor Dr Wan Azman Wan Ahmad shared his insights into the management of STEMI in Malaysia, highlighting the implications of the recent TREAT trial.
13 Aug 2018
At a lunch seminar hosted by GlaxoSmithKline (GSK) at the University of Malaya Medical Centre, Dr Annemiek de Ruiter spoke on the recent updates on dolutegravir (Tivicay, GSK) as an ideal antiretroviral (ARV) agent for the management of patients with human immunodeficiency virus (HIV) infection.
Conference Reports
Elaine Soliven, 17 Oct 2018

Adding insulin degludec/liraglutide to SGLT2i* may improve glycaemic control in patients with uncontrolled type 2 diabetes (T2D), according to the DUAL IX** trial presented at EASD 2018.

Roshini Claire Anthony, 16 Oct 2018

Overweight or obese patients taking lorcaserin as an appetite suppressant may have the added benefit of a reduced risk of incident diabetes, according to results of the CAMELLIA-TIMI 61* trial presented at EASD 2018.

Audrey Abella, 16 Oct 2018
Individuals with diabetes have a higher risk of osteoarthritis, rheumatoid arthritis (RA), and osteoporosis, according to a Danish study presented at EASD 2018.
Jackey Suen, 16 Oct 2018

Age ≥60 years and ≥20 percent of normal lung volume receiving a radiation dose of ≥20 Gy (V20) are significant predictors of radiation pneumonitis (RP) in patients treated with intensity-modulated radiotherapy (IMRT) for lung cancer, a Chinese study has shown.

Jackey Suen, 16 Oct 2018

Reduction in gross tumour volume (GTV) during concurrent chemoradiation therapy (CRT) may be linked to worse overall survival (OS) in patients with locally advanced lung adenocarcinoma, according to a recent study reported at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer (WCLC 2018).

Elaine Soliven, 16 Oct 2018
The use of degludec in insulin-naïve patients with type 2 diabetes (T2D) appears to reduce HbA1c levels with a lower risk of hypoglycaemia, based on real-world data from the CONFIRM* trial presented at EASD 2018.
Audrey Abella, 15 Oct 2018
Reducing salt intake is one of the most practical ways to help tackle hypertension, according to data presented at AFCC 2018.
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download